Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients

Author： van der Straaten RJHM   Wessels Judith AM   de Vries-Bouwstra Jeska K   Goekoop-Ruiterman Yvonne PM   Allaart Cornelia F   Bogaartz Judith   Tiller Marco   Huizinga Tom WJ   Guchelaar Henk-Jan  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.2, 2007-02, pp. : 141-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Associations between the C677T and A1298C Polymorphisms of MTHFR and the Efficacy and Toxicity of Methotrexate in Rheumatoid Arthritis: A Meta-Analysis

By >   >  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate

By Hu Chuanpu   Xu Zhenhua   Rahman Mahboob   Davis Hugh   Zhou Honghui  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 4, 2010-08 ,pp. : 309-321

Springer Publishing Company

Access to resources Recommend Favorite

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2763-2768

John Wiley & Sons Inc

Access to resources Recommend Favorite

Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis

By Kooloos Wouter M   Wessels Judith AM   van der Straaten Tahar   Allaart Cornelia F   Huizinga Tom WJ   Guchelaar Henk-Jan  

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 163-175

Future Medicine

Access to resources Recommend Favorite

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 6, 2014-11 ,pp. : 456-465

John Wiley & Sons Inc

Access to resources Recommend Favorite